Wilson's disease: A review

Journal of the Pakistan Medical Association

Volumn 54, Issue 9, 2004, Pages 479-484

  Hassan, A ^a   Masood, F ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ANTIOXIDANT; CERULOPLASMIN; CHELATING AGENT; COPPER; DNA; FREE RADICAL; GLYCOPROTEIN; METALLOTHIONEIN; PENICILLAMINE; PYRIDOXINE; TETRATHIOMOLYBDIC ACID; TRIENTINE; ZINC DERIVATIVE;

AUTOIMMUNE DISEASE; AUTOSOMAL RECESSIVE DISORDER; BIOACCUMULATION; CLINICAL FEATURE; COPPER BLOOD LEVEL; COPPER METABOLISM; DIAGNOSTIC TEST; DIET THERAPY; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG MECHANISM; DRUG TOLERABILITY; ENZYME ACTIVITY; EOSINOPHILIA; EXTRAPYRAMIDAL SYMPTOM; FEVER; GENE IDENTIFICATION; GOODPASTURE SYNDROME; HEMORRHAGIC GASTRITIS; HUMAN; INBORN ERROR OF METABOLISM; INTESTINE ABSORPTION; LEUKOPENIA; LIPID PEROXIDATION; LIVER DISEASE; LIVER LEVEL; LIVER TOXICITY; LIVER TRANSPLANTATION; LUPUS ERYTHEMATOSUS; LUPUS ERYTHEMATOSUS NEPHRITIS; LYMPHADENOPATHY; MYASTHENIA; NEPHRITIS; NEUROIMAGING; NEUROLOGIC DISEASE; PANCREATITIS; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PREVALENCE; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN SYNTHESIS; PROTEIN SYNTHESIS INHIBITION; RASH; REVIEW; SIDEROBLASTIC ANEMIA; SLIT LAMP; SPLENOMEGALY; STOMACH DISEASE; THROMBOCYTOPENIA; URINE LEVEL; WILSON DISEASE;

ADOLESCENT; ADULT; BIOPSY, NEEDLE; CHILD; COMBINED MODALITY THERAPY; DIET; DRUG THERAPY, COMBINATION; FEMALE; HEPATOLENTICULAR DEGENERATION; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PAKISTAN; PROGNOSIS; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 6344259963     PISSN: 00309982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (34)

1. Wilson SAK. Progressive lenticular degeneration: a familial nervous disease associated with cirrhosis of the liver. Brain 1912;34:295-507.
2. Vulpe C, Levenson B, Whitney S, et al. Isolation of a candidate gene for Menkes' disease and evidence that it encodes a copper-transporting ATPase. Nature Genet 1993;3:7-13.
3. Bull PC, Thomas GR, Rommens JM, et al. The Wilson's disease gene is a putative copper transporting P-type ATPase similar to the Menkes' gene. Nature Genet 1993;5:327-37.
4. Hung IH, Suzuki M, Yamaguchi Y, et al. Biochemical characterization of the Wilson's disease protein and functional expression in the yeast Saccharomyces cerevisiae. J Biol Chem 1997;272:21461-6.
5. Terada K, Kawarda Y. Muira N, et al. Copper incorporation into ceruloplasmin in rat livers. Biochem Biophys Acta 1995;1270:58-62.
6. Weiner WJ, Lang AE. Movement disorders: In: Mt Kisco, eds.A Comprehensive Survey., New York: Futura Publishing Co. 1989; pp. 257-91.
7. Walshe JM, Yealland M. Wilson's disease: The problems of delayed diagnosis. J Neirol Neurosurg Psychiatry 1992;55:692-96.
8. Strickland GT, Leu ML. Wilson's disease: clinical and laboratory manifestations in 40 patients. Medicine 1975;54:113-37.
9. Akil M, Brewer GJ. Psychiatric and behavioral abnormalities in Wilson's disease. Adv Neurol 1995;65:171-8.
10. Yarze JC, Martin P, Munor SJ, et al. Wilson's disease: current status. Am J Med 1992;92:643-54.
11. Bellary SV, Van Thiel DH. Wilson's disease: a diagnosis made in two individuals greater than 40 yeasr of age. J Okla stat Med Assoc 1993:86:441-4.
12. Shaver WA, Bhartt H, Combes B. Low serum alkaline phosphatase activity in Wilson's disease. Hepatology 1986;6:859.
13. Innes JR, Strachan IM, Triger DR. Unilateral Kayser-Fleischer ring. Br J Ophthalmol 1979:70:469-70.
14. Tauber J, Steinert RF. Psuedo-Kayser-Fleisher ring of the cornea associated with non-Wilsonian liver disease: A case report and literature review. Cornea 1993;12:74-7.
15. Demirkiran M, Jankovic J, Lewis RA, Cox DW. Neurologic presentation of Wilson disease without Kayser-Fleischer rings. Neurology 1996;46:1040-43.
16. Gow PJ, Smallwood RA, Angus PW, et al. Diagnosis of Wilson's disease: an experience over three decades. Gut 2000;46:415-19.
17. Gross JB, Jr., Ludwig J, Wiesner RH, et al. Abnormalities in tests of copper metabolism in primary sclerosing cholangitis. Gastroenterology 1985;89:272-8.
18. Sancher-Albisua I, Garde T, Hierro L, et al. A high index of suspicion: the key to an early diagnosis of Wilson's disease in childhood. J Pediatr Gastroenterol Nutr 1999;28:186-90.
19. Eve AR, Michael LS. A practice Guidelines on Wilson's disease. Hepatology 2003;37:1475-92.
20. Lau JY, Lai CL, Wu PC, et al. Wilson's disease: 35 years' experience. Q J Med 1990;75:597-605.
21. Gaffney D, Fell GS, O'Reilly DS. ACP Best Practice No 163. Wilson's disease: acute and presymptomatic laboratory diagnosis and monitoring. J Clin Pathol 2000;53:807-12.
22. Ronald F. Wilson's Disease. In: Ray LW, William CK, eds. Movement disorders, neurologic principles and practice. New York: McGraw-Hill, 1996, pp. 623-37.
23. van Wassenaer-van Hall HN, van den Heuvel AG, Algra A, et al. Wilson disease: findings at MR imaging and CT of the brain with clinical correlation. Radiology 1996;198:531-36.
24. Maier-Dobersberger T, Mannhalter C, Rack S, et al. Diagnosis of Wilson's disease in an asymptomatic sibling by DNA linkage analysis. Gastroenterology 1995;109:2015-18.
25. Brewer GJ, Yuzbasiyan-Gurkan V, Dick R, et al. Does a vegetarian diet control Wilson's disease? J Am Coll Nutr 1993;12:527-30.
26. Czlonkowska A, Gajda J, Rodo M. Effects of long-term treatment in Wilson's disease with D-penicillamine and zinc sulphate. J Neurol 1996;243:269-73.
27. Simon SR. Treatment of Wilson's disease. In: Roger K, eds. Treatment of movement disorders. Philadelphia: Lippincott, 1995, pp.115-51.
28. Walshe JM, Yealland M. Chelation treatment of neurological Wilson's disease. Q J Med 1993;86:197-204.
29. Brewer GJ, Terry CA, Aisen AM, et al. Worsening of neurologic syndrome in patients with Wilson's disease with initial penicillamine therapy. Arch Neurol 1987;44:490-93.
30. Scheinberg IH, Jaffe ME, Sternlieb I. The use of trientine in preventing the effects of interrupting penicillamine therapy in Wilson's disease. N Engl J Med 1987;317:209-13.
31. Santos Silva EE, Sarles J, Buts JP, et al. Successful medical treatment of severely decompensated Wilson disease. J Pediatr 1996;128:285-7.
32. Brewer GJ, Johnson V, Dick RD, et al. Treatment of Wilson disease with ammonium tetrathiomolybdate. II. Initial therapy in 33 neurologically affected patients and follow-up with zinc therapy. Arch Neurol 1996;53:1017-25.
33. Eghtesad B, Nezakatgoo N, Geraci LC, et al. Liver transplantation for Wilson's disease: a single-center experience. Liver Transpl Surg 1999;5:467-74.
34. Scilsky MI, Scheinberg IH, Sternlieb I. Prognosis of Wilsonian chronic active hepatitis. Gastroenterology 1991;100:762-7.